Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pharmacological probes of Ras function.

¹Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486.

Seminars in Cancer Biology

|December 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.

Prostate cancer and prostatic diseases·2002

Same author

Medical laser safety hazard evaluation.

Health physics·2002

Same author

Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.

Journal of medicinal chemistry·2001

Same author

Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase.

Bioorganic & medicinal chemistry letters·2001

Same author

Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.

Radiation research·2000

Same author

Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.

Cancer research·2000

Same journal

Role of oral microbiome in cancer immunotherapy.

Seminars in cancer biology·2026

Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026

Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026

Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026

Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026

Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026

See all related articles

Researchers are exploring various anti-Ras drug strategies, from broad screening to targeted mechanism-based designs. These approaches aim to identify novel interventions by understanding Ras oncogene protein regulation and function.

Area of Science:

Oncology
Drug Discovery
Molecular Biology

Background:

Ras oncogene proteins are critical regulators of cellular signaling pathways.
Dysregulation of Ras proteins is implicated in numerous human cancers.
Developing effective anti-Ras therapies remains a significant challenge in oncology.

Purpose of the Study:

To review current and emerging strategies for developing anti-Ras drugs.
To highlight the diverse methodologies employed in anti-Ras drug discovery.
To identify key intervention points within Ras signaling pathways.

Main Methods:

Screening of fermentation products using cell-based assays.
Structure-based and mechanism-based in vitro screening.
Detailed investigation of Ras protein function and regulation.

Related Experiment Videos

Main Results:

Multiple drug discovery approaches are under investigation.
Mechanism-based strategies leverage extensive knowledge of Ras biology.
Potential intervention points include protein expression, localization, and activation.

Conclusions:

A multifaceted approach is necessary for effective anti-Ras drug development.
Understanding Ras regulation provides critical targets for therapeutic intervention.
Continued research is vital for advancing anti-Ras therapies.